Cardinal
  • Home
  • Template Catalog
  • About
  • Resources
  • Help
    • Getting Started
    • Report a Bug
    • FAQ

Subjects With Adverse Events by Female-Specific OCMQ (Broad) and Preferred Term, Female Safety Population, Pooled Analysis (or Trial X)

FDA Table 45

table
FDA
safety
adverse events

FDA IG Shell

FDA IG example table shell

Programming Notes

Background and Instructions

As discussed in Section 3.2.3.3 Subjects With Adverse Events by Sex-Specific OND Custom Medical Queries (Narrow) and Preferred Term, some OCMQs are relevant to only one sex. Table 44: Adverse Events by Male Specific FDA Medical Query is limited to male-specific broad OCMQs and the male population. Table 45: Adverse Events by Female Specific FDA Medical Query is limited to female-specific broad OCMQs and the female population.

Customization

N/A (per FDA IG)

Output

  • Full Code
  • Table
  • ARD
Code
# FDA TABLE 45 ---------------------------------------------------------------
# Self-contained template. Run top-to-bottom to build the objects below.
# Used by tests via run_template() and published in the catalog.

library(dplyr)
library(cards)
library(gtsummary)

adsl <- pharmaverseadam::adsl
adae <- pharmaverseadam::adae

set.seed(1)
adae <- adae |>
  mutate(
    OCMQ01SC = as.factor(sample(c("BROAD", "NARROW"), nrow(adae), replace = TRUE)),
    OCMQ01NAM = if_else(
      SEX == "F",
      as.factor(sample(
        c("Abnormal Uterine Bleeding", "Amenorrhea", "Bacterial Vaginosis", "Decreased Menstrual Bleeding"),
        n(),
        replace = TRUE
      )),
      NA_character_
    )
  )

# Pre-processing --------------------------------------------
data <- adae |>
  filter(
    SAFFL == "Y",
    SEX == "F",
    OCMQ01SC == "BROAD",
    # Filtering to reduce the size of the demo table
    AEDECOD %in% c("APPLICATION SITE IRRITATION", "ERYTHEMA", "APPLICATION SITE PRURITUS", "BACK PAIN")
  ) |>
  select(OCMQ01SC, TRT01A, OCMQ01NAM, AEDECOD, USUBJID) |>
  # setting an explicit level for NA values so empty strata combinations are shown.
  mutate(across(everything(), ~ {
    if (anyNA(.)) {
      forcats::fct_na_value_to_level(as.factor(.), level = "<Missing>")
    } else {
      .
    }
  }))

# denominator values include only Female subjects in the arm with AEs
denom <- data |> distinct(USUBJID, TRT01A)

tbl <- data |>
  tbl_hierarchical(
    by = TRT01A,
    variables = c(OCMQ01NAM, AEDECOD),
    id = USUBJID,
    denominator = denom,
    # variables to calculate rates for
    include = c(AEDECOD),
    label = list(
      OCMQ01NAM ~ "OCMQ (Broad)",
      AEDECOD ~ "Preferred Term"
    )
  )


ard <- gtsummary::gather_ard(tbl)
Code
tbl
OCMQ (Broad)
    Preferred Term
Placebo
N = 71
Xanomeline High Dose
N = 131
Xanomeline Low Dose
N = 201
Abnormal Uterine Bleeding


    APPLICATION SITE IRRITATION 1 (14%) 1 (7.7%) 1 (5.0%)
    APPLICATION SITE PRURITUS 0 (0%) 3 (23%) 2 (10%)
    ERYTHEMA 1 (14%) 1 (7.7%) 2 (10%)
Amenorrhea


    APPLICATION SITE IRRITATION 1 (14%) 2 (15%) 0 (0%)
    APPLICATION SITE PRURITUS 0 (0%) 0 (0%) 7 (35%)
    ERYTHEMA 0 (0%) 1 (7.7%) 2 (10%)
Bacterial Vaginosis


    APPLICATION SITE IRRITATION 0 (0%) 2 (15%) 2 (10%)
    APPLICATION SITE PRURITUS 1 (14%) 2 (15%) 3 (15%)
    ERYTHEMA 1 (14%) 1 (7.7%) 3 (15%)
Decreased Menstrual Bleeding


    APPLICATION SITE IRRITATION 1 (14%) 1 (7.7%) 1 (5.0%)
    APPLICATION SITE PRURITUS 0 (0%) 3 (23%) 1 (5.0%)
    BACK PAIN 1 (14%) 0 (0%) 0 (0%)
    ERYTHEMA 2 (29%) 0 (0%) 3 (15%)
1 n (%)
Code
withr::local_options(width = 9999, tibble.print_max = Inf)
print(ard, columns = "all")
$tbl_hierarchical
# An ARD data frame: 126 × 15
    group1 group1_level         group2    group2_level                 variable variable_level              context      stat_name stat_label    stat stat_fmt fmt_fun warning error  gts_column
    <chr>  <list>               <chr>     <list>                       <chr>    <list>                      <chr>        <chr>     <chr>       <list> <list>   <list>  <list>  <list> <chr>     
  1 <NA>   <NULL>               <NA>      <NULL>                       TRT01A   Placebo                     tabulate     n         n           7      7        0       <NULL>  <NULL> stat_1    
  2 <NA>   <NULL>               <NA>      <NULL>                       TRT01A   Placebo                     tabulate     N         N          40      40       0       <NULL>  <NULL> stat_1    
  3 <NA>   <NULL>               <NA>      <NULL>                       TRT01A   Placebo                     tabulate     p         %           0.175  17.5     <fn>    <NULL>  <NULL> stat_1    
  4 <NA>   <NULL>               <NA>      <NULL>                       TRT01A   Xanomeline High Dose        tabulate     n         n          13      13       0       <NULL>  <NULL> stat_2    
  5 <NA>   <NULL>               <NA>      <NULL>                       TRT01A   Xanomeline High Dose        tabulate     N         N          40      40       0       <NULL>  <NULL> stat_2    
  6 <NA>   <NULL>               <NA>      <NULL>                       TRT01A   Xanomeline High Dose        tabulate     p         %           0.325  32.5     <fn>    <NULL>  <NULL> stat_2    
  7 <NA>   <NULL>               <NA>      <NULL>                       TRT01A   Xanomeline Low Dose         tabulate     n         n          20      20       0       <NULL>  <NULL> stat_3    
  8 <NA>   <NULL>               <NA>      <NULL>                       TRT01A   Xanomeline Low Dose         tabulate     N         N          40      40       0       <NULL>  <NULL> stat_3    
  9 <NA>   <NULL>               <NA>      <NULL>                       TRT01A   Xanomeline Low Dose         tabulate     p         %           0.5    50.0     <fn>    <NULL>  <NULL> stat_3    
 10 TRT01A Placebo              OCMQ01NAM Abnormal Uterine Bleeding    AEDECOD  APPLICATION SITE IRRITATION hierarchical n         n           1      1        <fn>    <NULL>  <NULL> stat_1    
 11 TRT01A Placebo              OCMQ01NAM Abnormal Uterine Bleeding    AEDECOD  APPLICATION SITE IRRITATION hierarchical N         N           7      7        <fn>    <NULL>  <NULL> stat_1    
 12 TRT01A Placebo              OCMQ01NAM Abnormal Uterine Bleeding    AEDECOD  APPLICATION SITE IRRITATION hierarchical p         %           0.143  14       <fn>    <NULL>  <NULL> stat_1    
 13 TRT01A Xanomeline High Dose OCMQ01NAM Abnormal Uterine Bleeding    AEDECOD  APPLICATION SITE IRRITATION hierarchical n         n           1      1        <fn>    <NULL>  <NULL> stat_2    
 14 TRT01A Xanomeline High Dose OCMQ01NAM Abnormal Uterine Bleeding    AEDECOD  APPLICATION SITE IRRITATION hierarchical N         N          13      13       <fn>    <NULL>  <NULL> stat_2    
 15 TRT01A Xanomeline High Dose OCMQ01NAM Abnormal Uterine Bleeding    AEDECOD  APPLICATION SITE IRRITATION hierarchical p         %           0.0769 7.7      <fn>    <NULL>  <NULL> stat_2    
 16 TRT01A Xanomeline Low Dose  OCMQ01NAM Abnormal Uterine Bleeding    AEDECOD  APPLICATION SITE IRRITATION hierarchical n         n           1      1        <fn>    <NULL>  <NULL> stat_3    
 17 TRT01A Xanomeline Low Dose  OCMQ01NAM Abnormal Uterine Bleeding    AEDECOD  APPLICATION SITE IRRITATION hierarchical N         N          20      20       <fn>    <NULL>  <NULL> stat_3    
 18 TRT01A Xanomeline Low Dose  OCMQ01NAM Abnormal Uterine Bleeding    AEDECOD  APPLICATION SITE IRRITATION hierarchical p         %           0.05   5.0      <fn>    <NULL>  <NULL> stat_3    
 19 TRT01A Placebo              OCMQ01NAM Abnormal Uterine Bleeding    AEDECOD  APPLICATION SITE PRURITUS   hierarchical n         n           0      0        <fn>    <NULL>  <NULL> stat_1    
 20 TRT01A Placebo              OCMQ01NAM Abnormal Uterine Bleeding    AEDECOD  APPLICATION SITE PRURITUS   hierarchical N         N           7      7        <fn>    <NULL>  <NULL> stat_1    
 21 TRT01A Placebo              OCMQ01NAM Abnormal Uterine Bleeding    AEDECOD  APPLICATION SITE PRURITUS   hierarchical p         %           0      0        <fn>    <NULL>  <NULL> stat_1    
 22 TRT01A Xanomeline High Dose OCMQ01NAM Abnormal Uterine Bleeding    AEDECOD  APPLICATION SITE PRURITUS   hierarchical n         n           3      3        <fn>    <NULL>  <NULL> stat_2    
 23 TRT01A Xanomeline High Dose OCMQ01NAM Abnormal Uterine Bleeding    AEDECOD  APPLICATION SITE PRURITUS   hierarchical N         N          13      13       <fn>    <NULL>  <NULL> stat_2    
 24 TRT01A Xanomeline High Dose OCMQ01NAM Abnormal Uterine Bleeding    AEDECOD  APPLICATION SITE PRURITUS   hierarchical p         %           0.231  23       <fn>    <NULL>  <NULL> stat_2    
 25 TRT01A Xanomeline Low Dose  OCMQ01NAM Abnormal Uterine Bleeding    AEDECOD  APPLICATION SITE PRURITUS   hierarchical n         n           2      2        <fn>    <NULL>  <NULL> stat_3    
 26 TRT01A Xanomeline Low Dose  OCMQ01NAM Abnormal Uterine Bleeding    AEDECOD  APPLICATION SITE PRURITUS   hierarchical N         N          20      20       <fn>    <NULL>  <NULL> stat_3    
 27 TRT01A Xanomeline Low Dose  OCMQ01NAM Abnormal Uterine Bleeding    AEDECOD  APPLICATION SITE PRURITUS   hierarchical p         %           0.1    10       <fn>    <NULL>  <NULL> stat_3    
 28 TRT01A Placebo              OCMQ01NAM Abnormal Uterine Bleeding    AEDECOD  ERYTHEMA                    hierarchical n         n           1      1        <fn>    <NULL>  <NULL> stat_1    
 29 TRT01A Placebo              OCMQ01NAM Abnormal Uterine Bleeding    AEDECOD  ERYTHEMA                    hierarchical N         N           7      7        <fn>    <NULL>  <NULL> stat_1    
 30 TRT01A Placebo              OCMQ01NAM Abnormal Uterine Bleeding    AEDECOD  ERYTHEMA                    hierarchical p         %           0.143  14       <fn>    <NULL>  <NULL> stat_1    
 31 TRT01A Xanomeline High Dose OCMQ01NAM Abnormal Uterine Bleeding    AEDECOD  ERYTHEMA                    hierarchical n         n           1      1        <fn>    <NULL>  <NULL> stat_2    
 32 TRT01A Xanomeline High Dose OCMQ01NAM Abnormal Uterine Bleeding    AEDECOD  ERYTHEMA                    hierarchical N         N          13      13       <fn>    <NULL>  <NULL> stat_2    
 33 TRT01A Xanomeline High Dose OCMQ01NAM Abnormal Uterine Bleeding    AEDECOD  ERYTHEMA                    hierarchical p         %           0.0769 7.7      <fn>    <NULL>  <NULL> stat_2    
 34 TRT01A Xanomeline Low Dose  OCMQ01NAM Abnormal Uterine Bleeding    AEDECOD  ERYTHEMA                    hierarchical n         n           2      2        <fn>    <NULL>  <NULL> stat_3    
 35 TRT01A Xanomeline Low Dose  OCMQ01NAM Abnormal Uterine Bleeding    AEDECOD  ERYTHEMA                    hierarchical N         N          20      20       <fn>    <NULL>  <NULL> stat_3    
 36 TRT01A Xanomeline Low Dose  OCMQ01NAM Abnormal Uterine Bleeding    AEDECOD  ERYTHEMA                    hierarchical p         %           0.1    10       <fn>    <NULL>  <NULL> stat_3    
 37 TRT01A Placebo              OCMQ01NAM Amenorrhea                   AEDECOD  APPLICATION SITE IRRITATION hierarchical n         n           1      1        <fn>    <NULL>  <NULL> stat_1    
 38 TRT01A Placebo              OCMQ01NAM Amenorrhea                   AEDECOD  APPLICATION SITE IRRITATION hierarchical N         N           7      7        <fn>    <NULL>  <NULL> stat_1    
 39 TRT01A Placebo              OCMQ01NAM Amenorrhea                   AEDECOD  APPLICATION SITE IRRITATION hierarchical p         %           0.143  14       <fn>    <NULL>  <NULL> stat_1    
 40 TRT01A Xanomeline High Dose OCMQ01NAM Amenorrhea                   AEDECOD  APPLICATION SITE IRRITATION hierarchical n         n           2      2        <fn>    <NULL>  <NULL> stat_2    
 41 TRT01A Xanomeline High Dose OCMQ01NAM Amenorrhea                   AEDECOD  APPLICATION SITE IRRITATION hierarchical N         N          13      13       <fn>    <NULL>  <NULL> stat_2    
 42 TRT01A Xanomeline High Dose OCMQ01NAM Amenorrhea                   AEDECOD  APPLICATION SITE IRRITATION hierarchical p         %           0.154  15       <fn>    <NULL>  <NULL> stat_2    
 43 TRT01A Xanomeline Low Dose  OCMQ01NAM Amenorrhea                   AEDECOD  APPLICATION SITE IRRITATION hierarchical n         n           0      0        <fn>    <NULL>  <NULL> stat_3    
 44 TRT01A Xanomeline Low Dose  OCMQ01NAM Amenorrhea                   AEDECOD  APPLICATION SITE IRRITATION hierarchical N         N          20      20       <fn>    <NULL>  <NULL> stat_3    
 45 TRT01A Xanomeline Low Dose  OCMQ01NAM Amenorrhea                   AEDECOD  APPLICATION SITE IRRITATION hierarchical p         %           0      0        <fn>    <NULL>  <NULL> stat_3    
 46 TRT01A Placebo              OCMQ01NAM Amenorrhea                   AEDECOD  APPLICATION SITE PRURITUS   hierarchical n         n           0      0        <fn>    <NULL>  <NULL> stat_1    
 47 TRT01A Placebo              OCMQ01NAM Amenorrhea                   AEDECOD  APPLICATION SITE PRURITUS   hierarchical N         N           7      7        <fn>    <NULL>  <NULL> stat_1    
 48 TRT01A Placebo              OCMQ01NAM Amenorrhea                   AEDECOD  APPLICATION SITE PRURITUS   hierarchical p         %           0      0        <fn>    <NULL>  <NULL> stat_1    
 49 TRT01A Xanomeline High Dose OCMQ01NAM Amenorrhea                   AEDECOD  APPLICATION SITE PRURITUS   hierarchical n         n           0      0        <fn>    <NULL>  <NULL> stat_2    
 50 TRT01A Xanomeline High Dose OCMQ01NAM Amenorrhea                   AEDECOD  APPLICATION SITE PRURITUS   hierarchical N         N          13      13       <fn>    <NULL>  <NULL> stat_2    
 51 TRT01A Xanomeline High Dose OCMQ01NAM Amenorrhea                   AEDECOD  APPLICATION SITE PRURITUS   hierarchical p         %           0      0        <fn>    <NULL>  <NULL> stat_2    
 52 TRT01A Xanomeline Low Dose  OCMQ01NAM Amenorrhea                   AEDECOD  APPLICATION SITE PRURITUS   hierarchical n         n           7      7        <fn>    <NULL>  <NULL> stat_3    
 53 TRT01A Xanomeline Low Dose  OCMQ01NAM Amenorrhea                   AEDECOD  APPLICATION SITE PRURITUS   hierarchical N         N          20      20       <fn>    <NULL>  <NULL> stat_3    
 54 TRT01A Xanomeline Low Dose  OCMQ01NAM Amenorrhea                   AEDECOD  APPLICATION SITE PRURITUS   hierarchical p         %           0.35   35       <fn>    <NULL>  <NULL> stat_3    
 55 TRT01A Placebo              OCMQ01NAM Amenorrhea                   AEDECOD  ERYTHEMA                    hierarchical n         n           0      0        <fn>    <NULL>  <NULL> stat_1    
 56 TRT01A Placebo              OCMQ01NAM Amenorrhea                   AEDECOD  ERYTHEMA                    hierarchical N         N           7      7        <fn>    <NULL>  <NULL> stat_1    
 57 TRT01A Placebo              OCMQ01NAM Amenorrhea                   AEDECOD  ERYTHEMA                    hierarchical p         %           0      0        <fn>    <NULL>  <NULL> stat_1    
 58 TRT01A Xanomeline High Dose OCMQ01NAM Amenorrhea                   AEDECOD  ERYTHEMA                    hierarchical n         n           1      1        <fn>    <NULL>  <NULL> stat_2    
 59 TRT01A Xanomeline High Dose OCMQ01NAM Amenorrhea                   AEDECOD  ERYTHEMA                    hierarchical N         N          13      13       <fn>    <NULL>  <NULL> stat_2    
 60 TRT01A Xanomeline High Dose OCMQ01NAM Amenorrhea                   AEDECOD  ERYTHEMA                    hierarchical p         %           0.0769 7.7      <fn>    <NULL>  <NULL> stat_2    
 61 TRT01A Xanomeline Low Dose  OCMQ01NAM Amenorrhea                   AEDECOD  ERYTHEMA                    hierarchical n         n           2      2        <fn>    <NULL>  <NULL> stat_3    
 62 TRT01A Xanomeline Low Dose  OCMQ01NAM Amenorrhea                   AEDECOD  ERYTHEMA                    hierarchical N         N          20      20       <fn>    <NULL>  <NULL> stat_3    
 63 TRT01A Xanomeline Low Dose  OCMQ01NAM Amenorrhea                   AEDECOD  ERYTHEMA                    hierarchical p         %           0.1    10       <fn>    <NULL>  <NULL> stat_3    
 64 TRT01A Placebo              OCMQ01NAM Bacterial Vaginosis          AEDECOD  APPLICATION SITE IRRITATION hierarchical n         n           0      0        <fn>    <NULL>  <NULL> stat_1    
 65 TRT01A Placebo              OCMQ01NAM Bacterial Vaginosis          AEDECOD  APPLICATION SITE IRRITATION hierarchical N         N           7      7        <fn>    <NULL>  <NULL> stat_1    
 66 TRT01A Placebo              OCMQ01NAM Bacterial Vaginosis          AEDECOD  APPLICATION SITE IRRITATION hierarchical p         %           0      0        <fn>    <NULL>  <NULL> stat_1    
 67 TRT01A Xanomeline High Dose OCMQ01NAM Bacterial Vaginosis          AEDECOD  APPLICATION SITE IRRITATION hierarchical n         n           2      2        <fn>    <NULL>  <NULL> stat_2    
 68 TRT01A Xanomeline High Dose OCMQ01NAM Bacterial Vaginosis          AEDECOD  APPLICATION SITE IRRITATION hierarchical N         N          13      13       <fn>    <NULL>  <NULL> stat_2    
 69 TRT01A Xanomeline High Dose OCMQ01NAM Bacterial Vaginosis          AEDECOD  APPLICATION SITE IRRITATION hierarchical p         %           0.154  15       <fn>    <NULL>  <NULL> stat_2    
 70 TRT01A Xanomeline Low Dose  OCMQ01NAM Bacterial Vaginosis          AEDECOD  APPLICATION SITE IRRITATION hierarchical n         n           2      2        <fn>    <NULL>  <NULL> stat_3    
 71 TRT01A Xanomeline Low Dose  OCMQ01NAM Bacterial Vaginosis          AEDECOD  APPLICATION SITE IRRITATION hierarchical N         N          20      20       <fn>    <NULL>  <NULL> stat_3    
 72 TRT01A Xanomeline Low Dose  OCMQ01NAM Bacterial Vaginosis          AEDECOD  APPLICATION SITE IRRITATION hierarchical p         %           0.1    10       <fn>    <NULL>  <NULL> stat_3    
 73 TRT01A Placebo              OCMQ01NAM Bacterial Vaginosis          AEDECOD  APPLICATION SITE PRURITUS   hierarchical n         n           1      1        <fn>    <NULL>  <NULL> stat_1    
 74 TRT01A Placebo              OCMQ01NAM Bacterial Vaginosis          AEDECOD  APPLICATION SITE PRURITUS   hierarchical N         N           7      7        <fn>    <NULL>  <NULL> stat_1    
 75 TRT01A Placebo              OCMQ01NAM Bacterial Vaginosis          AEDECOD  APPLICATION SITE PRURITUS   hierarchical p         %           0.143  14       <fn>    <NULL>  <NULL> stat_1    
 76 TRT01A Xanomeline High Dose OCMQ01NAM Bacterial Vaginosis          AEDECOD  APPLICATION SITE PRURITUS   hierarchical n         n           2      2        <fn>    <NULL>  <NULL> stat_2    
 77 TRT01A Xanomeline High Dose OCMQ01NAM Bacterial Vaginosis          AEDECOD  APPLICATION SITE PRURITUS   hierarchical N         N          13      13       <fn>    <NULL>  <NULL> stat_2    
 78 TRT01A Xanomeline High Dose OCMQ01NAM Bacterial Vaginosis          AEDECOD  APPLICATION SITE PRURITUS   hierarchical p         %           0.154  15       <fn>    <NULL>  <NULL> stat_2    
 79 TRT01A Xanomeline Low Dose  OCMQ01NAM Bacterial Vaginosis          AEDECOD  APPLICATION SITE PRURITUS   hierarchical n         n           3      3        <fn>    <NULL>  <NULL> stat_3    
 80 TRT01A Xanomeline Low Dose  OCMQ01NAM Bacterial Vaginosis          AEDECOD  APPLICATION SITE PRURITUS   hierarchical N         N          20      20       <fn>    <NULL>  <NULL> stat_3    
 81 TRT01A Xanomeline Low Dose  OCMQ01NAM Bacterial Vaginosis          AEDECOD  APPLICATION SITE PRURITUS   hierarchical p         %           0.15   15       <fn>    <NULL>  <NULL> stat_3    
 82 TRT01A Placebo              OCMQ01NAM Bacterial Vaginosis          AEDECOD  ERYTHEMA                    hierarchical n         n           1      1        <fn>    <NULL>  <NULL> stat_1    
 83 TRT01A Placebo              OCMQ01NAM Bacterial Vaginosis          AEDECOD  ERYTHEMA                    hierarchical N         N           7      7        <fn>    <NULL>  <NULL> stat_1    
 84 TRT01A Placebo              OCMQ01NAM Bacterial Vaginosis          AEDECOD  ERYTHEMA                    hierarchical p         %           0.143  14       <fn>    <NULL>  <NULL> stat_1    
 85 TRT01A Xanomeline High Dose OCMQ01NAM Bacterial Vaginosis          AEDECOD  ERYTHEMA                    hierarchical n         n           1      1        <fn>    <NULL>  <NULL> stat_2    
 86 TRT01A Xanomeline High Dose OCMQ01NAM Bacterial Vaginosis          AEDECOD  ERYTHEMA                    hierarchical N         N          13      13       <fn>    <NULL>  <NULL> stat_2    
 87 TRT01A Xanomeline High Dose OCMQ01NAM Bacterial Vaginosis          AEDECOD  ERYTHEMA                    hierarchical p         %           0.0769 7.7      <fn>    <NULL>  <NULL> stat_2    
 88 TRT01A Xanomeline Low Dose  OCMQ01NAM Bacterial Vaginosis          AEDECOD  ERYTHEMA                    hierarchical n         n           3      3        <fn>    <NULL>  <NULL> stat_3    
 89 TRT01A Xanomeline Low Dose  OCMQ01NAM Bacterial Vaginosis          AEDECOD  ERYTHEMA                    hierarchical N         N          20      20       <fn>    <NULL>  <NULL> stat_3    
 90 TRT01A Xanomeline Low Dose  OCMQ01NAM Bacterial Vaginosis          AEDECOD  ERYTHEMA                    hierarchical p         %           0.15   15       <fn>    <NULL>  <NULL> stat_3    
 91 TRT01A Placebo              OCMQ01NAM Decreased Menstrual Bleeding AEDECOD  APPLICATION SITE IRRITATION hierarchical n         n           1      1        <fn>    <NULL>  <NULL> stat_1    
 92 TRT01A Placebo              OCMQ01NAM Decreased Menstrual Bleeding AEDECOD  APPLICATION SITE IRRITATION hierarchical N         N           7      7        <fn>    <NULL>  <NULL> stat_1    
 93 TRT01A Placebo              OCMQ01NAM Decreased Menstrual Bleeding AEDECOD  APPLICATION SITE IRRITATION hierarchical p         %           0.143  14       <fn>    <NULL>  <NULL> stat_1    
 94 TRT01A Xanomeline High Dose OCMQ01NAM Decreased Menstrual Bleeding AEDECOD  APPLICATION SITE IRRITATION hierarchical n         n           1      1        <fn>    <NULL>  <NULL> stat_2    
 95 TRT01A Xanomeline High Dose OCMQ01NAM Decreased Menstrual Bleeding AEDECOD  APPLICATION SITE IRRITATION hierarchical N         N          13      13       <fn>    <NULL>  <NULL> stat_2    
 96 TRT01A Xanomeline High Dose OCMQ01NAM Decreased Menstrual Bleeding AEDECOD  APPLICATION SITE IRRITATION hierarchical p         %           0.0769 7.7      <fn>    <NULL>  <NULL> stat_2    
 97 TRT01A Xanomeline Low Dose  OCMQ01NAM Decreased Menstrual Bleeding AEDECOD  APPLICATION SITE IRRITATION hierarchical n         n           1      1        <fn>    <NULL>  <NULL> stat_3    
 98 TRT01A Xanomeline Low Dose  OCMQ01NAM Decreased Menstrual Bleeding AEDECOD  APPLICATION SITE IRRITATION hierarchical N         N          20      20       <fn>    <NULL>  <NULL> stat_3    
 99 TRT01A Xanomeline Low Dose  OCMQ01NAM Decreased Menstrual Bleeding AEDECOD  APPLICATION SITE IRRITATION hierarchical p         %           0.05   5.0      <fn>    <NULL>  <NULL> stat_3    
100 TRT01A Placebo              OCMQ01NAM Decreased Menstrual Bleeding AEDECOD  APPLICATION SITE PRURITUS   hierarchical n         n           0      0        <fn>    <NULL>  <NULL> stat_1    
101 TRT01A Placebo              OCMQ01NAM Decreased Menstrual Bleeding AEDECOD  APPLICATION SITE PRURITUS   hierarchical N         N           7      7        <fn>    <NULL>  <NULL> stat_1    
102 TRT01A Placebo              OCMQ01NAM Decreased Menstrual Bleeding AEDECOD  APPLICATION SITE PRURITUS   hierarchical p         %           0      0        <fn>    <NULL>  <NULL> stat_1    
103 TRT01A Xanomeline High Dose OCMQ01NAM Decreased Menstrual Bleeding AEDECOD  APPLICATION SITE PRURITUS   hierarchical n         n           3      3        <fn>    <NULL>  <NULL> stat_2    
104 TRT01A Xanomeline High Dose OCMQ01NAM Decreased Menstrual Bleeding AEDECOD  APPLICATION SITE PRURITUS   hierarchical N         N          13      13       <fn>    <NULL>  <NULL> stat_2    
105 TRT01A Xanomeline High Dose OCMQ01NAM Decreased Menstrual Bleeding AEDECOD  APPLICATION SITE PRURITUS   hierarchical p         %           0.231  23       <fn>    <NULL>  <NULL> stat_2    
106 TRT01A Xanomeline Low Dose  OCMQ01NAM Decreased Menstrual Bleeding AEDECOD  APPLICATION SITE PRURITUS   hierarchical n         n           1      1        <fn>    <NULL>  <NULL> stat_3    
107 TRT01A Xanomeline Low Dose  OCMQ01NAM Decreased Menstrual Bleeding AEDECOD  APPLICATION SITE PRURITUS   hierarchical N         N          20      20       <fn>    <NULL>  <NULL> stat_3    
108 TRT01A Xanomeline Low Dose  OCMQ01NAM Decreased Menstrual Bleeding AEDECOD  APPLICATION SITE PRURITUS   hierarchical p         %           0.05   5.0      <fn>    <NULL>  <NULL> stat_3    
109 TRT01A Placebo              OCMQ01NAM Decreased Menstrual Bleeding AEDECOD  BACK PAIN                   hierarchical n         n           1      1        <fn>    <NULL>  <NULL> stat_1    
110 TRT01A Placebo              OCMQ01NAM Decreased Menstrual Bleeding AEDECOD  BACK PAIN                   hierarchical N         N           7      7        <fn>    <NULL>  <NULL> stat_1    
111 TRT01A Placebo              OCMQ01NAM Decreased Menstrual Bleeding AEDECOD  BACK PAIN                   hierarchical p         %           0.143  14       <fn>    <NULL>  <NULL> stat_1    
112 TRT01A Xanomeline High Dose OCMQ01NAM Decreased Menstrual Bleeding AEDECOD  BACK PAIN                   hierarchical n         n           0      0        <fn>    <NULL>  <NULL> stat_2    
113 TRT01A Xanomeline High Dose OCMQ01NAM Decreased Menstrual Bleeding AEDECOD  BACK PAIN                   hierarchical N         N          13      13       <fn>    <NULL>  <NULL> stat_2    
114 TRT01A Xanomeline High Dose OCMQ01NAM Decreased Menstrual Bleeding AEDECOD  BACK PAIN                   hierarchical p         %           0      0        <fn>    <NULL>  <NULL> stat_2    
115 TRT01A Xanomeline Low Dose  OCMQ01NAM Decreased Menstrual Bleeding AEDECOD  BACK PAIN                   hierarchical n         n           0      0        <fn>    <NULL>  <NULL> stat_3    
116 TRT01A Xanomeline Low Dose  OCMQ01NAM Decreased Menstrual Bleeding AEDECOD  BACK PAIN                   hierarchical N         N          20      20       <fn>    <NULL>  <NULL> stat_3    
117 TRT01A Xanomeline Low Dose  OCMQ01NAM Decreased Menstrual Bleeding AEDECOD  BACK PAIN                   hierarchical p         %           0      0        <fn>    <NULL>  <NULL> stat_3    
118 TRT01A Placebo              OCMQ01NAM Decreased Menstrual Bleeding AEDECOD  ERYTHEMA                    hierarchical n         n           2      2        <fn>    <NULL>  <NULL> stat_1    
119 TRT01A Placebo              OCMQ01NAM Decreased Menstrual Bleeding AEDECOD  ERYTHEMA                    hierarchical N         N           7      7        <fn>    <NULL>  <NULL> stat_1    
120 TRT01A Placebo              OCMQ01NAM Decreased Menstrual Bleeding AEDECOD  ERYTHEMA                    hierarchical p         %           0.286  29       <fn>    <NULL>  <NULL> stat_1    
121 TRT01A Xanomeline High Dose OCMQ01NAM Decreased Menstrual Bleeding AEDECOD  ERYTHEMA                    hierarchical n         n           0      0        <fn>    <NULL>  <NULL> stat_2    
122 TRT01A Xanomeline High Dose OCMQ01NAM Decreased Menstrual Bleeding AEDECOD  ERYTHEMA                    hierarchical N         N          13      13       <fn>    <NULL>  <NULL> stat_2    
123 TRT01A Xanomeline High Dose OCMQ01NAM Decreased Menstrual Bleeding AEDECOD  ERYTHEMA                    hierarchical p         %           0      0        <fn>    <NULL>  <NULL> stat_2    
124 TRT01A Xanomeline Low Dose  OCMQ01NAM Decreased Menstrual Bleeding AEDECOD  ERYTHEMA                    hierarchical n         n           3      3        <fn>    <NULL>  <NULL> stat_3    
125 TRT01A Xanomeline Low Dose  OCMQ01NAM Decreased Menstrual Bleeding AEDECOD  ERYTHEMA                    hierarchical N         N          20      20       <fn>    <NULL>  <NULL> stat_3    
126 TRT01A Xanomeline Low Dose  OCMQ01NAM Decreased Menstrual Bleeding AEDECOD  ERYTHEMA                    hierarchical p         %           0.15   15       <fn>    <NULL>  <NULL> stat_3    
Source Code
---
title: Subjects With Adverse Events by Female-Specific OCMQ (Broad) and Preferred Term, Female Safety Population, Pooled Analysis (or Trial X)
subtitle: FDA Table 45
categories: [table, FDA, safety, adverse events]
---

::::: columns

:::: {.column width="52%"}
### FDA IG Shell

![](ig_shell.png){fig-alt="FDA IG example table shell" .lightbox width=100%}

### Programming Notes

**Background and Instructions**

As discussed in Section 3.2.3.3 Subjects With Adverse Events by Sex-Specific OND Custom Medical Queries (Narrow) and Preferred Term, some OCMQs are relevant to only one sex. Table 44: Adverse Events by Male Specific FDA Medical Query is limited to male-specific broad OCMQs and the male population. Table 45: Adverse Events by Female Specific FDA Medical Query is limited to female-specific broad OCMQs and the female population.

**Customization**

[N/A (per FDA IG)](https://www.fda.gov/media/187065/download)

::::

:::: {.column width="4%"}
::::

:::: {.column width="44%"}
### Output

```{r out-result, echo=FALSE, fig.align='center', out.width='100%'}
knitr::include_graphics("result.png")
```

::::

:::::

::: panel-tabset
## Full Code

```{r fullcode, file="../../../inst/templates/fda-table_45.R", message=FALSE, warning=FALSE, results='hide'}
```

## Table

```{r tbl}
tbl
```

## ARD

```{r ard, message=FALSE, warning=FALSE}
withr::local_options(width = 9999, tibble.print_max = Inf)
print(ard, columns = "all")
```

:::
 
  • This website as well as code examples are licensed under the Apache License, Version 2.0.
Cookie Preferences